23andMe is a biotechnology company that provides genetic testing services for consumers interested in exploring their ancestry, inherited traits, and potential health predispositions. The service involves DNA analysis which helps individuals gain insights into their genetic health, ancestries, and traits, making it appealing to those curious about genetic data-driven personal health and ancestry exploration.
23andMe products and services overview:
Employees: 700
23andMe is a company listed under the stock ticker ME (US).
They are in:
Acquisition, funding and merger involving 23andMe.
View the org chart displaying its 23 main executives
Click here to view some more movements at 23andMe
Create your alert
to follow the executive moves at 23andMe.
23andMe has 2,353 competitors including Incyte (United States (USA)), Anthos Therapeutics (United States (USA)) and Valneva (France).
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.